Doximity (NYSE:DOCS) Rating Increased to Strong-Buy at Canaccord Genuity Group

Canaccord Genuity Group upgraded shares of Doximity (NYSE:DOCS) from a hold rating to a strong-buy rating in a report released on Monday morning,Zacks.com reports.

Several other equities research analysts also recently issued reports on DOCS. Royal Bank Of Canada upgraded shares of Doximity to a “moderate buy” rating in a research note on Thursday, January 8th. Wells Fargo & Company upgraded Doximity from an “equal weight” rating to an “overweight” rating and set a $55.00 price target for the company in a report on Tuesday, January 20th. Zacks Research raised Doximity from a “hold” rating to a “strong-buy” rating in a research report on Monday, January 26th. Truist Financial raised Doximity from a “hold” rating to a “strong-buy” rating in a research report on Thursday, January 8th. Finally, Weiss Ratings reiterated a “hold (c+)” rating on shares of Doximity in a research note on Wednesday, December 24th. Four investment analysts have rated the stock with a Strong Buy rating, three have given a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Buy” and an average target price of $55.00.

Doximity Stock Down 0.8%

Shares of NYSE:DOCS opened at $27.51 on Monday. The business’s 50-day moving average price is $41.14. The stock has a market cap of $5.18 billion, a PE ratio of 22.93, a P/E/G ratio of 1.29 and a beta of 1.39. Doximity has a 1 year low of $23.66 and a 1 year high of $85.21.

About Doximity

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.